TIME Pharmaceuticals : Touching Lives, Delivering Promises
"गुणस्तरीय औषधी हाम्रो पहिचान; स्वस्थ्य नेपाल हाम्रो अभियान"
TIME Pharmaceuticals: Thrive For Effectiveness
SIGN of HOPE : AstraZeneca to supply Europe with up to 40 million doses of Vaccine: If success will be milestone in treatment of COVID 19
Jun 15, 2020
AstraZeneca has reached an agreement with Europe's Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and Netherlands, to supply up to 400 million doses of the University of Oxford's COVID-19 vaccine, with deliveries starting by the end of 2020.With today's agreement, the IVA aims to accelerate the supply of the vaccine and to make it available to other European countries that wish to participate in the initiative. The IVA is committed to providing equitable access to all participating countries across Europe. AstraZeneca continues to build a number of supply chains in parallel across the world, including for Europe. The Company is seeking to expand manufacturing capacity further and is open to collaborating with other companies in order to meet its commitment to support access to the vaccine at no profit during the pandemic.